✦ LIBER ✦

387 A phase I study of AEE788, a novel multi-targeted inhibitor of ErbB and VEGF receptor family tyrosine kinases

✍ Scribed by H. Dumez; P. Clement; C.H. Takimoto; A.T. van Oosterom; A. Mita; K. Parker; E.K. Rowinsky; R. Salazar; E. Martinelli; J. Baselga

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

412 A phase I and pharmacokinetic study

✍ A. Mita; C.H. Takimoto; E. Martinelli; H. Dumez; C. DiLea; W. Mietlowski; J. Tab 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Phase I study of AEE788, a novel multita

✍ Reardon, David A.; Conrad, Charles A.; Cloughesy, Timothy; Prados, Michael D.; F 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 416 KB

367 Emerging pharmacokinetic (PK)-pharma

✍ J. Baselga; F. Rojo; A. van Oosterom; H. Dumez; J. Huang; E. Walk; A. Mita; E. R 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 284 KB

621 POSTER A phase I study of combinatio

✍ D. Reardon; T. Cloughesy; J. Rich; W. Yung; C. Cilea; W. Mietlowski; L. Yung; W. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A phase I, first-in-human dose-escalatio

✍ Raoul Tibes, Gil Fine, Gavin Choy, Sanjeev Redkar… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 232 KB

P-359 Results from a phase I study of th

✍ Wheeler, Catherine; Minami, Hironobu; Ebi, Hiromichi; Tahara, Makoto; Sasaki, Ya 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB